Bondalti Capital acquires Ercros
Bondalti has successfully acquired a controlling stake in Ercros, with the acceptance of 77.23% of its shares following a takeover bid. The acquisition, involving a payment of €3.5 per share, positions Bondalti to potentially pursue further corporate actions, including the potential of a delisting move. The bid's acceptance by the majority of Ercros's shareholders solidifies Bondalti's entry in the chemicals sector amidst challenging market conditions.
Ercros's remaining shares, representing roughly 23% of the company, remain publicly traded but with diminished liquidity due to the significant reduction in the free float. Notably, Joan Casas Galofré and their family, holding approximately 10.8% of the shares, have opted not to participate in the takeover bid. The transaction is expected to be finalized shortly, with settlement anticipated within two business days following the announcement of the full result on March 24, 2026.
Bondalti's strategic acquisition of Ercros is driven by several possible directions. The Portuguese chemicals company may choose to maintain Ercros as a publicly-listed entity while it increases shareholdings through market purchases or considers a delisting takeover. The continuation of Ercros on the stock exchange appears momentarily intact, though Bondalti has indicated the possibility of pursuing a delisting offer at a maximum of €3.505 per share, subject to regulatory requirements.
Within the broader market context, this acquisition reflects capital allocation challenges in a declining sector, where firms are navigating market price pressures and stringent regulations. Despite a decrease in Ercros's share price by 1.6% to €3.45, the potential for a delisting offer provides a support mechanism, with market anticipation hinging on Bondalti's future strategic decisions and regulatory approvals.
Going forward, Bondalti's potential decision to initiate a delisting bid will require adherence to "fair price" standards overseen by the Spanish regulator, the CNMV. Any move to exit the stock exchange will involve a thorough evaluation of market dynamics and stakeholder interests, indicating a crucial period of review and decision-making for both Bondalti and the remaining shareholders of Ercros.
Deal timeline
This transaction is classified in Chemical Manufacturing (325) with a reported deal value of €3.5K. Figures and status may change as sources update.